| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.33 | 2e-13 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.21 | 7e-07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.21 | 6e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.052 | 0.2 |